Junyu He

412 total citations
25 papers, 212 citations indexed

About

Junyu He is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Junyu He has authored 25 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Junyu He's work include Eosinophilic Esophagitis (4 papers), IL-33, ST2, and ILC Pathways (4 papers) and Immune Cell Function and Interaction (3 papers). Junyu He is often cited by papers focused on Eosinophilic Esophagitis (4 papers), IL-33, ST2, and ILC Pathways (4 papers) and Immune Cell Function and Interaction (3 papers). Junyu He collaborates with scholars based in China, Ethiopia and Uganda. Junyu He's co-authors include Songshu Xiao, Yanhong Zhou, Xiao‐Yan Jiang, Yingyu Dou, Hui Xie, Guofeng Xu, Xi Jin, Tian-Ci Wang, Yuxiong Guo and Yumei He and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemosphere and Journal of Environmental Management.

In The Last Decade

Junyu He

22 papers receiving 211 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junyu He China 9 94 68 44 30 30 25 212
Timna Varela Martins Brazil 6 122 1.3× 109 1.6× 52 1.2× 20 0.7× 37 1.2× 9 277
Federica Rubbino Italy 8 96 1.0× 57 0.8× 43 1.0× 36 1.2× 80 2.7× 10 229
Deborah Lavin United Kingdom 7 120 1.3× 32 0.5× 29 0.7× 29 1.0× 32 1.1× 12 229
Xianhai Zeng China 10 111 1.2× 59 0.9× 69 1.6× 16 0.5× 32 1.1× 33 273
Gabriel Azevedo Públio Brazil 6 127 1.4× 135 2.0× 56 1.3× 21 0.7× 40 1.3× 7 297
Yeke Wu China 9 139 1.5× 45 0.7× 110 2.5× 23 0.8× 22 0.7× 20 323
Brandon Mapes United States 8 84 0.9× 39 0.6× 42 1.0× 15 0.5× 27 0.9× 10 218
Sooryeonhwa Jin South Korea 6 109 1.2× 62 0.9× 52 1.2× 20 0.7× 14 0.5× 7 230
Peter YF. Zeng Canada 9 101 1.1× 26 0.4× 57 1.3× 41 1.4× 59 2.0× 28 238

Countries citing papers authored by Junyu He

Since Specialization
Citations

This map shows the geographic impact of Junyu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyu He more than expected).

Fields of papers citing papers by Junyu He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyu He. The network helps show where Junyu He may publish in the future.

Co-authorship network of co-authors of Junyu He

This figure shows the co-authorship network connecting the top 25 collaborators of Junyu He. A scholar is included among the top collaborators of Junyu He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyu He. Junyu He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhuang, Lu, Boyu Ji, Yan Ren, et al.. (2025). Ultrasonic cavitation treatment of o-cresol wastewater and long-term pilot-scale study. Journal of Environmental Management. 375. 124208–124208. 3 indexed citations
2.
Li, Xinyao, Yimin Chen, Junyu He, et al.. (2025). Endothelial cell–ILC3 crosstalk via the ET-1/EDNRA axis promotes NKp46+ILC3 glycolysis to alleviate intestinal inflammation. Cellular and Molecular Immunology. 22(11). 1459–1477.
3.
He, Junyu, Guilang Zheng, Chunling Chen, et al.. (2024). GPX4 restricts ferroptosis of NKp46+ILC3s to control intestinal inflammation. Cell Death and Disease. 15(9). 687–687. 14 indexed citations
4.
Zhang, Xiaogang, Jingping Liu, Xinyao Li, et al.. (2024). Blocking the HIF‐1α/glycolysis axis inhibits allergic airway inflammation by reducing ILC2 metabolism and function. Allergy. 80(5). 1309–1334. 16 indexed citations
5.
Sun, Haohao, Jie Li, Lu Zhuang, et al.. (2024). Treatment of high concentration phenol wastewater by low-frequency ultrasonic cavitation and long-term pilot scale study. Chemosphere. 370. 143937–143937. 2 indexed citations
6.
Xing, Zhe, Xinyao Li, Junyu He, et al.. (2024). OLFM4 modulates intestinal inflammation by promoting IL-22+ILC3 in the gut. Communications Biology. 7(1). 914–914. 7 indexed citations
7.
He, Junyu, Peng Han, Nian Liu, et al.. (2023). Plasma extrachromosomal circular DNA is a pathophysiological hallmark of short‐term intensive insulin therapy for type 2 diabetes. Clinical and Translational Medicine. 13(10). e1437–e1437. 13 indexed citations
8.
Zhu, Qing, et al.. (2022). HDL-Associated Lipoproteins: Potential Prognostic Biomarkers for Gram-Negative Sepsis. SHILAP Revista de lepidopterología.
9.
He, Junyu, et al.. (2022). Identification of Novel Compound Heterozygous Variants of the PNPLA6 Gene in Boucher–Neuhäuser Syndrome. Frontiers in Genetics. 13. 810537–810537. 3 indexed citations
10.
Zeng, Feng, Junyu He, Xi Jin, et al.. (2022). FRA-1: A key factor regulating signal transduction of tumor cells and a potential target molecule for tumor therapy. Biomedicine & Pharmacotherapy. 150. 113037–113037. 11 indexed citations
11.
He, Junyu & Zhihong Liao. (2021). Osteogenesis Imperfecta With Cerebral Atherosclerosis: A Family Report. Journal of the Endocrine Society. 5(Supplement_1). A209–A209. 1 indexed citations
12.
Zou, Huajie, Ping Yin, Wenjun Li, et al.. (2020). Durability of glycaemic control in type 2 diabetes: A systematic review and meta‐analysis for its association with body weight changes. Diabetes Obesity and Metabolism. 23(1). 208–217. 4 indexed citations
13.
Liang, Lin, et al.. (2020). Fra-1 Inhibits Cell Growth and the Warburg Effect in Cervical Cancer Cells via STAT1 Regulation of the p53 Signaling Pathway. Frontiers in Cell and Developmental Biology. 8. 579629–579629. 22 indexed citations
14.
Dou, Yingyu, Xiao‐Yan Jiang, Hui Xie, Junyu He, & Songshu Xiao. (2019). The Jun N-terminal kinases signaling pathway plays a “seesaw” role in ovarian carcinoma: a molecular aspect. Journal of Ovarian Research. 12(1). 99–99. 28 indexed citations
15.
Liu, Ting, Lin Liang, Junyu He, et al.. (2019). Clinical relationships between the rs2212020 and rs189897 polymorphisms of the ITGA9 gene and epithelial ovarian cancer. Journal of Genetics. 98(1). 1 indexed citations
16.
Huang, Yiran, Guofeng Xu, Junyu He, et al.. (2017). Serum levels of anti‑sperm‑associated antigen 9 antibody are elevated in patients with hepatocellular carcinoma. Oncology Letters. 14(6). 7608–7614. 6 indexed citations
17.
He, Junyu, et al.. (2016). The delta high-density lipoprotein cholesterol ratio: a novel parameter for gram-negative sepsis. SpringerPlus. 5(1). 1044–1044. 14 indexed citations
18.
He, Junyu, Guofeng Xu, Yiran Huang, et al.. (2016). Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer. Oncology Reports. 35(5). 2599–2605. 17 indexed citations
19.
Pei, Zhen, Xiao-Lei Huo, Lu Gao, et al.. (2015). CD24 promotes the proliferation and inhibits the apoptosis of cervical cancer cells in vitro. Oncology Reports. 35(3). 1593–1601. 23 indexed citations
20.
Hou, Juan, Junyu He, Xin Jin, Tao Hu, & Yu Zhang. (2013). Study on optimisation of extraction process of Tanshinone IIA and its mechanism of induction of gastric cancer SGC7901 cellapoptosis. African Journal of Traditional Complementary and Alternative Medicines. 10(6). 456–456. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026